Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1992 2
1994 1
1995 1
1996 1
1998 2
1999 4
2000 1
2001 1
2002 1
2009 1
2010 2
2011 2
2012 2
2013 1
2014 3
2015 4
2016 2
2017 1
2018 4
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.
Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, López Corral L, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Olavarría E, Quintana N, García JL, Bladé J, Lahuerta JJ, San Miguel JF. Mateos MV, et al. N Engl J Med. 2013 Aug 1;369(5):438-47. doi: 10.1056/NEJMoa1300439. N Engl J Med. 2013. PMID: 23902483 Free article. Clinical Trial.
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.
Lahuerta JJ, Paiva B, Vidriales MB, Cordón L, Cedena MT, Puig N, Martinez-Lopez J, Rosiñol L, Gutierrez NC, Martín-Ramos ML, Oriol A, Teruel AI, Echeveste MA, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Martin A, Alegre A, De la Rubia J, Orfao A, Mateos MV, Blade J, San-Miguel JF; GEM (Grupo Español de Mieloma)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group. Lahuerta JJ, et al. J Clin Oncol. 2017 Sep 1;35(25):2900-2910. doi: 10.1200/JCO.2016.69.2517. Epub 2017 May 12. J Clin Oncol. 2017. PMID: 28498784 Free PMC article.
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.
Rosiñol L, Oriol A, Teruel AI, Hernández D, López-Jiménez J, de la Rubia J, Granell M, Besalduch J, Palomera L, González Y, Etxebeste MA, Díaz-Mediavilla J, Hernández MT, de Arriba F, Gutiérrez NC, Martín-Ramos ML, Cibeira MT, Mateos MV, Martínez J, Alegre A, Lahuerta JJ, San Miguel J, Bladé J; Programa para el Estudio y la Terapéutica de las Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) group. Rosiñol L, et al. Blood. 2012 Aug 23;120(8):1589-96. doi: 10.1182/blood-2012-02-408922. Epub 2012 Jul 12. Blood. 2012. PMID: 22791289 Clinical Trial.
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, Corral LL, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Quintana N, García JL, Bladé J, Lahuerta JJ, Miguel JS. Mateos MV, et al. Lancet Oncol. 2016 Aug;17(8):1127-1136. doi: 10.1016/S1470-2045(16)30124-3. Epub 2016 Jul 9. Lancet Oncol. 2016. PMID: 27402145 Clinical Trial.
Chemometric characterization of the trace element profile of raw meat from Rubia Gallega x Holstein Friesian calves from an intensive system.
Gálvez F, López-Alonso M, Herrero-Latorre C, Miranda M, Franco D, Lorenzo JM. Gálvez F, et al. Meat Sci. 2019 Mar;149:63-69. doi: 10.1016/j.meatsci.2018.11.010. Epub 2018 Nov 15. Meat Sci. 2019. PMID: 30476859
Validation study of a scale for assessing three personality functional dimensions among Venezuelan HIV-positive patients.
de la Rubia JM, Andrade GPC, Yépez ACT, Guerra VML, López JAP, Sagarduy JLY. de la Rubia JM, et al. Psychol Res Behav Manag. 2018 Oct 12;11:459-470. doi: 10.2147/PRBM.S152038. eCollection 2018. Psychol Res Behav Manag. 2018. PMID: 30349412 Free PMC article.
Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform.
López M, Apraiz I, Rubia M, Piedrabuena M, Azkarate M, Veldhuisen B, Vesga MÁ, Van Der Schoot E, Puente F, Tejedor D. López M, et al. Blood Transfus. 2018 Feb;16(2):193-199. doi: 10.2450/2016.0146-16. Epub 2016 Nov 25. Blood Transfus. 2018. PMID: 27893355 Free PMC article.
Performance evaluation study of ID RHD XT, a new genotyping assay for the detection of high-prevalence RhD negative and weak D types.
Molano A, Apraiz I, España P, Azkarate M, Vesga MÁ, Rubia M, Piedrabuena M, Puente F, Veldhuisen B, van der Schoot E, Tejedor D, López M. Molano A, et al. Vox Sang. 2018 Oct;113(7):694-700. doi: 10.1111/vox.12701. Epub 2018 Aug 19. Vox Sang. 2018. PMID: 30125050
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis.
Cuenca I, Alameda D, Sanchez-Vega B, Gomez-Sanchez D, Alignani D, Lasa M, Onecha E, Lecumberri R, Prosper F, Ocio EM, González ME, García de Coca A, De La Rubia J, Gironella M, Palomera L, Oriol A, Casanova M, Cabañas V, Taboada F, Pérez-Montaña A, De Arriba F, Puig N, Carreño-Tarragona G, Barrio S, Enrique de la Puerta J, Ramirez-Payer A, Krsnik I, Bargay JJ, Lahuerta JJ, Mateos MV, San-Miguel JF, Paiva B, Lopez JM. Cuenca I, et al. Leukemia. 2020 Mar 19. doi: 10.1038/s41375-020-0800-6. Online ahead of print. Leukemia. 2020. PMID: 32203144 No abstract available.
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.
Lopez A, Mateos MV, Oriol A, Valero M, Martínez J, Lorenzo JI, Perez M, Martinez R, de Paz R, Granell M, De Arriba F, Blanchard MJ, Peñalver FJ, Bello JL, Martin ML, Bargay J, Blade J, Lahuerta JJ, San Miguel JF, de la Rubia J. Lopez A, et al. Leuk Res Rep. 2015 Sep 24;4(2):64-9. doi: 10.1016/j.lrr.2015.09.002. eCollection 2015. Leuk Res Rep. 2015. PMID: 26500850 Free PMC article.
38 results
Jump to page
Feedback